Results 311 to 320 of about 363,022 (358)
Some of the next articles are maybe not open access.
Allogeneic bone marrow transplantation
Seminars in Oncology Nursing, 1994From highly investigational to standardized therapy, allogeneic BMT has established its role in the treatment of selected diseases. Continued refinements in bone marrow transplantation will increase the number of potential candidates, reduce associated risks, and improve disease-free survival rates.
T, Franco, D A, Gould
openaire +2 more sources
The pathology of bone marrow transplantation
Histopathology, 1993The pathological complications of bone marrow transplantation are complex and may affect any organ in the body. The causes are often multifactorial and include the effects of chemotherapy, the conditioning regimen, drugs used in the post‐transplant period such as immunosuppressants and antibiotics, graft‐versus‐host disease (GvHD) and the effects of ...
J P, Sloane, J, Norton
openaire +2 more sources
Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1987
Since the 1970s major progress in bone marrow transplantation has resulted in long‐term survival and even cure for many patients with serious hematologic disease. Many patients undergoing the procedure, however, experience serious complications, including graft rejection, graft‐versus‐host disease, and infection.
openaire +2 more sources
Since the 1970s major progress in bone marrow transplantation has resulted in long‐term survival and even cure for many patients with serious hematologic disease. Many patients undergoing the procedure, however, experience serious complications, including graft rejection, graft‐versus‐host disease, and infection.
openaire +2 more sources
Autologous Bone Marrow Transplantation
Critical Reviews in Clinical Laboratory Sciences, 1995Autologous bone marrow transplantation has become a very popular and successful treatment for many patients with lymphomas and other malignancies. The current indications, pretreatment regimes, and laboratory manipulations are discussed as well as the application of gene transfer to eliminate selected genetic diseases and detect disease relapse.
Leo J. McCarthy +5 more
openaire +2 more sources
Critical Reviews in Oncology/Hematology, 1985
Bone marrow transplantation is increasingly used to treat a broad spectrum of human diseases including aplastic anemia, leukemia, solid tumors, immune and genetic disorders. In certain circumstances the role of transplantation is reasonably well established, such as aplastic anemia and resistant leukemia. In other circumstances there is controversey as
openaire +3 more sources
Bone marrow transplantation is increasingly used to treat a broad spectrum of human diseases including aplastic anemia, leukemia, solid tumors, immune and genetic disorders. In certain circumstances the role of transplantation is reasonably well established, such as aplastic anemia and resistant leukemia. In other circumstances there is controversey as
openaire +3 more sources
The history of bone-marrow transplantation
Blood Reviews, 1996As it influenced so much else this century, so the atomic bomb essentially marked the beginnings of interest in bone-marrow transplantation. The first detonation of a nuclear device in New Mexico in 1945, and the subsequent effects of the atomic bomb on the populations of Hiroslaima and Nagasaki provoked great and urgent interest in the effects of ...
A R, Perry, D C, Linch
openaire +2 more sources
Bone marrow transplantation retinopathy
International Ophthalmology, 2001Bone marrow transplantion (BMT) is the treatment of choice for both malignant and nonmalignant disorders of the bone marrow. BMT retinopathy occurs after a latent period of 6 months and usually recovers after a few weeks.We present a case of BMT retinopathy (BMT) in a patient with a high-degree of non-Hodgkin lymphoma.
F, Gómez-Ulla +3 more
openaire +2 more sources
Bone marrow transplantation for myelodysplasia
Blood Reviews, 2000Allogeneic bone marrow transplantation (BMT) is the only treatment modality that has consistently been demonstrated to cure patients with the myelodysplastic syndrome (MDS). Since the early 1980s, numerous publications have reported the results with BMT for over 700 patients with MDS and the lead patients are now disease-free for more than 16 years ...
openaire +2 more sources
An overview of bone marrow transplantation
Seminars in Oncology Nursing, 1988Abstract BMT has progressed from early isolated attempts in man through controlled animal studies in mice, rats, and dogs to the treatment of choice for some patients. 2 BMT is no longer a treatment of last resort for patients with acute leukemia; rather, it is seen as a viable alternative to conventional maintenance chemotherapy especially for ...
openaire +2 more sources
Bone marrow transplantation today
Supportive Care in Cancer, 1994Today, bone marrow transplantation (BMT) is an established therapy. This statement is best verified by the number of BMTs performed. Between January 1990 and December 1992, 172 European teams in 26 countries carried out a total of 14,334 transplants. There were 6642 allogeneic transplants: 5513 BMT from an HLA-identical sibling donor, 370 from a non ...
openaire +2 more sources